Promising new combo therapy aims for Long-Term control in multiple myeloma
NCT ID NCT06577025
First seen Oct 31, 2025 · Last updated May 03, 2026 · Updated 30 times
Summary
This study tests different sequences of advanced cell and antibody therapies (Cilta-cel, Tal-D, Tec-D) after initial chemotherapy in 43 people with newly diagnosed multiple myeloma. The goal is to see if these combinations can achieve deep, lasting remission with no detectable cancer cells for at least 2 years and clear scans at 5 years. While the study uses the term 'curative potential,' participants may still need ongoing monitoring or future treatment, so this is best described as aiming for long-term disease control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Fundacao Antonio Prudente A C Camargo Cancer Center
São Paulo, 01509 900, Brazil
-
Hosp Clinico Univ de Salamanca
Salamanca, 37007, Spain
-
Hosp. Univ. 12 de Octubre
Madrid, 28041, Spain
-
Hosp. Univ. Marques de Valdecilla
Santander, 39008, Spain
-
Instituto D Or de Pesquisa e Ensino
Salvador, 41253 190, Brazil
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Peter MacCallum Cancer Centre
Melbourne, 3000, Australia
-
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
São Paulo, 05652 900, Brazil
-
The Alfred Hospital
Melbourne, 3004, Australia
-
Universitaetsklinikum Heidelberg
Heidelberg, 69120, Germany
-
Universitaetsklinikum Tuebingen
Tübingen, 72076, Germany
-
Universitatsklinikum Wurzburg
Würzburg, 97080, Germany
-
University of California San Francisco
San Francisco, California, 94143, United States
-
University of Iowa Hospital and Clinics
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.